Serious adverse events occurred in 2.8% of participants in the SURPASS-2 study, which is less frequent than the 5.37% reported among tirzepatide users
The overarching conclusion was that oral semaglutide is beneficial for a diverse range of Japanese patients with type-2 diabetes, and no unforeseen safety issues were identified
Studies show that people who continue lifestyle changesregular movement, whole-food eating patterns, adequate protein intakemaintain 50-70% of their weight loss one year after discontinuing the medication
The GLP-1 Weight Loss Blueprint: A GLP-1 User & Registered Nurse's Guide to Fast, Consistent Results with Compounded & Brand-Name GLP-1s [Reid, M] on Amazon.com
It is a regulator of immune function, metabolic control, cognitive performance, and tissue repair